APRIL'S BIG RELEASES DOUBLE REWARDS

Close Notification

Your cart does not contain any items

$116

Paperback

Not in-store but you can order this
How long will it take?

QTY:

CRC Press
30 June 2020
At the present time, 430 drugs are known to cause respiratory injury. This represents an increase of almost 200 in the last ten years, and the number is still increasing. This comprehensive, definitive reference work, with an outstanding range of international expert contributors and two of the world's leading editors, provides an essential reference for the practising respiratory physician.

Key features:

The text builds upon basics with a review of basic sciences.

The book covers imaging, varied drug-induced interstitial lung disease including pulmonary edema and diffuse alveolar hemorrhage, acute respiratory failure, pleural involvement and upper to lower airway disease A wide range of diseases are detailed from chemotherapy and radiation to biologic-induced lung disease, drug misuse, and special groups such as recipients of stem cell and solid organ transplants.

A range of world class contributions from key opinion leaders.

This book provides essential information for recognizing and managing drug-induced respiratory disease for all pulmonologists and respiratory care physicians. It will be of great interest to: critical care medicine specialists, hematologists, oncologists, cardiologists, allergists, rheumatologists, neurologists, internists, blood-bank specialists, pathologists and primary care physicians.
By:   Phillipe Camus (Hopital du Bocage and Universite de Bourgogne Dijon France), Edward C Rosenow III (University of the Health Sciences, Brussels, Belgium)
Imprint:   CRC Press
Country of Publication:   United Kingdom
Dimensions:   Height: 280mm,  Width: 210mm, 
Weight:   454g
ISBN:   9780367452308
ISBN 10:   0367452308
Pages:   364
Publication Date:   30 June 2020
Audience:   College/higher education ,  Primary
Format:   Paperback
Publisher's Status:   Active
GENERAL Classification, diagnosis, and management of drug-induced respiratory disease Mechanisms of chemically induced respiratory toxicities Imaging of drug-induced lung disease Bronchoalveolar lavage in drug-induced lung disease Pathology of drug-induced respiratory disease Drug allergy in lung disease DRUG-INDUCED RESPIRATORY EMERGENCIES Drug-induced upper airway obstruction Drug-induced bronchospasm Drug-induced pulmonary oedema and acute respiratory distress syndrome Pulmonary complications of blood transfusion Drug-induced alveolar haemorrhage Pulmonary complications of illicit drug use Iatrogenic tracheobronchial and chest injury ONCOLOGY AND ALLIED CONDITIONS Pulmonary reactions to chemotherapeutic agents: The 'chemotherapy lung' Pulmonary reactions to novel chemotherapeutic agents and biomolecules Radiation-induced lung disease Pulmonary complications of bone-marrow and stem-cell transplantation Pulmonary complications of solid-organ transplantation Pulmonary infection induced by drugs Therapy-induced neoplasms NON-ONCOLOGICAL CONDITIONS Pneumonitis induced by non-cytotoxic agents Amiodarone pulmonary toxicity Eosinophilic pneumonia induced by drugs Bronchiolitis obliterans organizing pneumonia induced by drugs or radiotherapy Coughing induced by drugs Pleural disease induced by drugs Lupus erythematosus syndrome induced by drugs Vasculitis induced by drugs Pulmonary hypertension induced by drugs and toxins Respiratory involvement from herbals

Philippe Camus, MD Professor of Pulmonary Medicine, Department of Pulmonary and Critical Care Medicine, HApital du Bocage and UniversitA (c) de Bourgogne, Dijon, France Edward C Rosenow III, MD, MS, MACP, Master FCCP Emeritus Professor of Medicine, Former Chair Division of Pulmonary and Critical Care Medicine, Mayo Distinguished Clinician, Mayo Clinic School of Medicine, Rochester, Minnesota, USA

See Also